Company intelligence / Profile preview

Renjian Pharmaceutical

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Renjian Biopharma is a clinical-stage biotechnology company based in Shanghai, China, specializing in the development of mRNA-based therapeutics and vaccines. The company has established a comprehensive technology platform encompassing mRNA sequence design, synthesis, and lipid nanoparticle (LNP) delivery systems. Its primary focus areas include infectious disease prevention and cancer immunotherapy. Renjian Biopharma gained significant attention for its development of mRNA vaccine candidates, particularly during the COVID-19 pandemic, and continues to advance a pipeline of innovative nucleic acid medicines.

Therapeutic areas: OncologyInfectious Diseases
Modalities: mRNA-based drugsLipid nanoparticle delivery therapyVaccine
Industry: Biotech

Beyond the preview

Go deeper on Renjian Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renjian Pharmaceutical.

Explore the full profile